HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $53,225 | -7.9% | 51,675 | +3.7% | 0.00% | – |
Q2 2023 | $57,812 | -22.9% | 49,838 | +0.3% | 0.00% | – |
Q1 2023 | $75,002 | -38.4% | 49,670 | +2.0% | 0.00% | -100.0% |
Q4 2022 | $121,703 | -40.9% | 48,681 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $206,000 | +53.7% | 48,858 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $134,000 | -48.9% | 48,168 | +5.0% | 0.00% | 0.0% |
Q1 2022 | $262,000 | -41.5% | 45,869 | -6.6% | 0.00% | -50.0% |
Q4 2021 | $448,000 | -17.2% | 49,097 | -2.9% | 0.00% | -33.3% |
Q3 2021 | $541,000 | -32.6% | 50,567 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $803,000 | -3.0% | 51,768 | +1.4% | 0.00% | 0.0% |
Q1 2021 | $828,000 | -23.2% | 51,074 | +0.3% | 0.00% | -25.0% |
Q4 2020 | $1,078,000 | +38.7% | 50,938 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $777,000 | -1.4% | 52,400 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $788,000 | +34.9% | 53,592 | +7.7% | 0.00% | +33.3% |
Q1 2020 | $584,000 | -52.8% | 49,759 | -5.5% | 0.00% | -40.0% |
Q4 2019 | $1,237,000 | +43.5% | 52,634 | +12.9% | 0.01% | +66.7% |
Q3 2019 | $862,000 | -1.1% | 46,604 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $872,000 | -18.8% | 46,929 | +6.8% | 0.00% | -25.0% |
Q1 2019 | $1,074,000 | -8.8% | 43,956 | -3.1% | 0.00% | -20.0% |
Q4 2018 | $1,177,000 | -18.7% | 45,381 | -0.8% | 0.01% | 0.0% |
Q3 2018 | $1,447,000 | -10.4% | 45,731 | +10.0% | 0.01% | -16.7% |
Q2 2018 | $1,615,000 | +68.6% | 41,565 | +19.8% | 0.01% | +100.0% |
Q1 2018 | $958,000 | +72.9% | 34,709 | +13.4% | 0.00% | +50.0% |
Q4 2017 | $554,000 | +12.6% | 30,602 | +0.5% | 0.00% | 0.0% |
Q3 2017 | $492,000 | +26.2% | 30,457 | +8.1% | 0.00% | +100.0% |
Q2 2017 | $390,000 | +2.6% | 28,180 | +11.2% | 0.00% | 0.0% |
Q1 2017 | $380,000 | +59.0% | 25,332 | +38.6% | 0.00% | 0.0% |
Q4 2016 | $239,000 | -99.9% | 18,273 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $315,671,000 | -4.4% | 18,321 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $330,189,000 | +2.9% | 18,293 | +8.1% | 0.00% | 0.0% |
Q1 2016 | $321,000,000 | -16.6% | 16,924 | +17.2% | 0.00% | -50.0% |
Q4 2015 | $385,000,000 | +108965.2% | 14,435 | -0.2% | 0.00% | 0.0% |
Q3 2015 | $353,000 | -99.9% | 14,460 | +0.1% | 0.00% | 0.0% |
Q2 2015 | $450,044,000 | +111.2% | 14,443 | -1.4% | 0.00% | +100.0% |
Q1 2015 | $213,099,000 | +44.6% | 14,646 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $147,339,000 | +38.6% | 14,646 | +14.8% | 0.00% | – |
Q3 2014 | $106,291,000 | -34.8% | 12,760 | -3.6% | 0.00% | -100.0% |
Q2 2014 | $163,018,000 | +9667.4% | 13,232 | +10926.7% | 0.00% | – |
Q1 2014 | $1,669,000 | – | 120 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |